The additional share issuance adds to the already significant dilution from the July 15 offering and warrant exercises. With a $12M market cap and no revenue disclosed, the company is burning cash. Monitor for further capital needs or a reverse stock split to maintain NYSE American listing compliance.
Price Chart
Executive Summary
AEON Biopharma completed the partial exercise of the over-allotment option from its July 15, 2026 public offering, issuing 4,696,102 shares of Class A common stock for additional gross proceeds of approximately $1.5 million (net proceeds ~$1.4 million). This is a follow-up capital raise that adds modest dilution to a company with a $12M market cap, but the amounts are small relative to the prior offering's warrant coverage and the company's overall capital structure.
Key Facts
- Issued 4,696,102 shares of Class A common stock on July 23, 2026 via partial exercise of the over-allotment option.
- Additional gross proceeds of approximately $1.5 million; net proceeds of approximately $1.4 million after underwriting discounts.
- The representative had previously exercised in full the over-allotment option for warrants to purchase 6,403,290 shares of common stock or pre-funded warrants.
- Market cap is approximately $12M, making this a meaningful dilution event relative to existing shares.
Financial Impact
Additional gross proceeds of ~$1.5M from issuance of 4.7M new shares; net proceeds ~$1.4M. Combined with the prior full warrant exercise (6.4M shares), total potential dilution from the over-allotment is substantial for a $12M market cap company.
Risk Factors
- Further dilution from outstanding warrants (6.4M shares) if exercised.
- Cash burn rate and potential need for additional financing given pre-revenue status.
- NYSE American continued listing standards risk with low market cap and share price.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001837607-26-000055 |
| Document: 0001837607-26-000055-index-headers.html | 0001837607-26-000055 |
| Document: 0001837607-26-000055-index.html | 0001837607-26-000055 |
| Document: 0001837607-26-000055.txt | 0001837607-26-000055 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 8-K | $0.2399 | awaiting T+5 | — | $0.2400 (+0.04%) |
Sep 30, 2026 26d ago | 8-K | $0.3000 $0.3110 | ▲ +3.67% | ▲ +1.75% | $0.2400 (−20.00%) |
Aug 21, 2026 9w ago | 3 | $0.1974 $0.2959 | ▲ +49.90% | ▲ +49.43% | $0.2400 (+21.58%) |
Aug 19, 2026 9w ago | Press Release | $0.1980 $0.2515 | ▲ +27.02% | ▲ +27.41% | $0.2400 (+21.21%) |
Aug 12, 2026 10w ago | Press Release | $0.2706 $0.1931 | ▼ −28.64% | ▼ −26.68% | $0.2400 (−11.31%) |
Jul 23, 2026 13w ago | 8-K | $0.2507 $0.2552 | ▼ −1.79% | ▼ −1.42% | $0.2400 (+4.27%) |
Jul 15, 2026 14w ago | 8-K | $0.2974 $0.2600 | ▲ +12.58% | ▲ +10.91% | $0.2400 (+19.30%) |
Jul 15, 2026 14w ago | 424B4 | $0.2997 $0.2752 | ▲ +8.17% | ▲ +7.19% | $0.2400 (+19.92%) |
Jul 14, 2026 14w ago | EFFECT | $0.3570 $0.2890 | ▲ +19.05% | ▲ +17.75% | $0.2400 (+32.77%) |
Jul 9, 2026 15w ago | S-1/A | $0.5027 $0.2974 | ▲ +40.84% | ▲ +40.71% | $0.2400 (+52.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers